Coloplast's next acquisition will likely target a product or technology, CEO says
![Photo: Coloplast/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14321445.ece/ALTERNATES/schema-16_9/doc7mczs1rlayez7529hc6.jpg)
The integration of Coloplast’s newest division, Atos Medical, is going according to plan, says Coloplast CEO Kristian Villumsen, who is also keeping an eye out for new, but smaller, acquisitions – likely technology or product-related ones.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Coloplast presents strong Q3 figures
For subscribers
Coloplast raises prices to offset energy cost spikes
For subscribers